NYSE Analytics: July 23, 2014
NYSE Analytics: July 23, 2014
Spyder ETF grows before NYSE opening bell.
SPY (intraday chart) flat on premarket. Support 198.00, resistance 198.50.
Gapping up/down: BIIB +7%, PEP and BA +2% after earnings, TLM +11% on M&A spec, PBYI +245% after amending lic agreement w PFE and positive study data; JNPR and WHR -6% after earnings, KING -2% after dg.
In reaction to strong earnings/guidance:
JAKK +9.1%, VASC +7.1%, BIIB +6.7%, BABY +5.7%,MANH +5.4%, BEAV +4%, RHI +3.9%, ZIXI +3.7%, BRCM +3.5%,
GD +2.9%, RES +2.7%,UCFC +2.5%, VMW +2.3%, MSFT +2.3%, TMO +2.3%, PEP +2.3%, DOW +2%, DAL +2%,
BA+1.7%, FTI +1.2%, HA +1.1%, (also to add new Airbus (EADSY) A330-800neo to fleet; airline’s Order for A350XWB-800s cancelled ), AWRE +1%, EVR +0.9%, AAPL +0.7%, EMC +0.6%, .
M&A news: TLM +11.5% (hearing that Repsol (REPYY) is considering making a bid for the company).
Select battery related names showing strength again: FCEL +4%, PLUG +3.3% (co to host shareholder day today).
Other news: PBYI +245.7% (announces amendment to Neratinib licensing agreement with Pfizer; announces positive top line results from Phase III PB272 trial in Adjuvant Breast Cancer (ExteNET Trial); Neratinib achieves statistically significant improvement in disease free survival ), DARA +12.1% (following PBYI news), EGRX +7.1% (announces FDA approved Ryanodex for the Treatment of Malignant Hyperthermia; Orphan Drug Designation may Provide Eagle Seven Years Market Exclusivity), BLDP+4.6% (to supply New Flyer Industries with next generation Power Module for U.S. Fuel Cell Bus), UPIP+2.4% (co has sued Microsoft for breach of contract and declaratory judgment), ASX +2.4% (received Apple (AAPL) iWatch supplier orders, according to reports), DB +2.2% (late move lower on WSJ report suggesting the co may suffer from reporting problems, regulators say), DB +2.2% (rebounding after yesterday’s intraday selloff), GPRO +2.2% (on going volatility), P +2.1% (Google previously attempted to buy Spotify, according to WSJ report), CO +1.8% (Co and and Cordlife Group announced that the two companies have joined forces in assisting patients across asia), SAP +1.2% (still checking)
Analyst comments: CODE +1.6% (upgraded to Buy from Hold at Jefferies), ACT +1.6% (initiated with a Buy at Deutsche Bank), MNK +0.9% (initiated with a Buy at Deutsche Bank), PRGO +0.5% (initiated with a Buy at Deutsche Bank)
In reaction to disappointing earnings/guidance: XOOM -13%, XLNX -11.4%, UIS -7.3%, IRBT-6.5%, JNPR -6.3%, WHR -6.1%, EXP -5%, STM -4%, EA -3.7%, GSK -2.6%, LLTC -2.5%, ABB-1.7%, SYT -1.2%, OC -1.2%, TSS -0.7%, HERO -0.5%.
Other news: LJPC -7.1% (announces proposed underwritten offering of common stock), FPI -3.9% (announces commencement of public offering of common stock), ALTR -3.2% (following XLNX results),PT -3.2% (still checking), NYLD -1.5% (launches public offering of 10.5 mln shares of its Class A common stock), HLF -1.3% (ongoing Ackmann related volatility — was up nearly 14 pts yesterday), EVRY -1.3% (provided update on credit agreement: entered into amendment to extend the co’s forbearance agreement through July 29, 2014), HLF -1.3% (negative mention on Mad Money), MCD -0.9% (Five people were detained regarding China food probe, according to reports).
Analyst comments: KING -2.2% (downgraded at B of A/Merrill ), SHO -1.7% (downgraded to Neutral at Robert W. Baird), EAT -1.1% (downgraded to Sector Perform at RBC Capital Mkts), DD -1.1% (downgraded to Neutral from Overweight at JP Morgan and downgraded to Neutral from Outperform at Robert W. Baird), DRH -1.1% (downgraded to Neutral at Robert W. Baird), MCD -0.9% (downgraded to Neutral from Positive at Susquehanna).
Trading Ideas NYSE & NASDAQ:
- JNPR – short below 23.00
- XLNX – short below premarket low
- GPRO – long above premarket high
- TLM – short below 11.00